IGAN - IGA NEPHROPATHY
Clinical trials for IGAN - IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IGAN - IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for IGAN - IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody VIS649 tested in humans for first time to fight kidney disease
Disease control CompletedThis early-phase trial tested the safety of a new drug called VIS649 in 51 healthy volunteers. VIS649 is an antibody that blocks a protein called APRIL, which is thought to play a role in IgA nephropathy, a kidney disease. The study gave single doses of the drug or a placebo and …
Matched conditions: IGAN - IGA NEPHROPATHY
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 23, 2026 20:32 UTC
-
Massive global study reveals hidden burden of kidney disease in dialysis patients
Knowledge-focused CompletedThis study looked at information from about 70,000 adults receiving hemodialysis around the world to find out how many have IgA nephropathy (a type of kidney disease) and how it affects their health. Researchers compared patients with IgA nephropathy to other dialysis patients to…
Matched conditions: IGAN - IGA NEPHROPATHY
Sponsor: Arbor Research Collaborative for Health • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:03 UTC